NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO2,3-cPYRIDINE DERIVATIVES AS NIK INHIBITORS

摘要

The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-κB-inducing kinase (NIK, also known as MAP3K14) of formula (I) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The present invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.